{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:12:28Z","timestamp":1707523948979},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,17]]},"DOI":"10.7759\/cureus.47187","type":"journal-article","created":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T10:54:46Z","timestamp":1697540086000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical Characteristics and Prognostic Factors of Patients With Stenotrophomonas maltophilia Pneumonia: 10-Year Experience From a Single Center"],"prefix":"10.7759","author":[{"given":"Deniz","family":"K\u0131z\u0131l\u0131rmak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yavuz","family":"Havlucu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2012.01.001","article-title":"Stenotrophomonas maltophilia--the most worrisome threat among unusual non-fermentative gram-negative bacilli from hospitalized patients: a prospective multicenter study","volume":"64","author":"Fihman V","year":"2012","unstructured":"Fihman V, Le Monnier A, Corvec S, et al.. Stenotrophomonas maltophilia--the most worrisome threat among unusual non-fermentative gram-negative bacilli from hospitalized patients: a prospective multicenter study. J Infect. 2012, 64:391-8. 10.1016\/j.jinf.2012.01.001","journal-title":"J Infect"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2008.05.020","article-title":"Risk factors associated with mortality of infections caused by Stenotrophomonas maltophilia: a systematic review","volume":"70","author":"Paez JI","year":"2008","unstructured":"Paez JI, Costa SF. Risk factors associated with mortality of infections caused by Stenotrophomonas maltophilia: a systematic review. J Hosp Infect. 2008, 70:101-8. 10.1016\/j.jhin.2008.05.020","journal-title":"J Hosp Infect"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01324-13","article-title":"Monotherapy with fluoroquinolone or trimethoprim-sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections","volume":"58","author":"Wang YL","year":"2014","unstructured":"Wang YL, Scipione MR, Dubrovskaya Y, Papadopoulos J. Monotherapy with fluoroquinolone or trimethoprim-sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections. Antimicrob Agents Chemother. 2014, 58:176-82. 10.1128\/AAC.01324-13","journal-title":"Antimicrob Agents Chemother"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(09)70083-0","article-title":"Stenotrophomonas maltophilia: an emerging opportunist human pathogen","volume":"9","author":"Looney WJ","year":"2009","unstructured":"Looney WJ, Narita M, M\u00fchlemann K. Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect Dis. 2009, 9:312-23. 10.1016\/S1473-3099(09)70083-0","journal-title":"Lancet Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/23744235.2018.1531145","article-title":"Stenotrophomonas maltophilia - a low-grade pathogen with numerous virulence factors","volume":"51","author":"Trifonova A","year":"2019","unstructured":"Trifonova A, Strateva T. Stenotrophomonas maltophilia - a low-grade pathogen with numerous virulence factors. Infect Dis (Lond). 2019, 51:168-78. 10.1080\/23744235.2018.1531145","journal-title":"Infect Dis (Lond)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2014.01.007","article-title":"Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: results from the SENTRY Antimicrobial Surveillance Program, 2009-2012","volume":"43","author":"Sader HS","year":"2014","unstructured":"Sader HS, Farrell DJ, Flamm RK, Jones RN. Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: results from the SENTRY Antimicrobial Surveillance Program, 2009-2012. Int J Antimicrob Agents. 2014, 43:328-34. 10.1016\/j.ijantimicag.2014.01.007","journal-title":"Int J Antimicrob Agents"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1086\/341022","article-title":"Risk factors for late-onset nosocomial pneumonia caused by Stenotrophomonas maltophilia in critically ill trauma patients","volume":"35","author":"Hanes SD","year":"2002","unstructured":"Hanes SD, Demirkan K, Tolley E, Boucher BA, Croce MA, Wood GC, Fabian TC. Risk factors for late-onset nosocomial pneumonia caused by Stenotrophomonas maltophilia in critically ill trauma patients. Clin Infect Dis. 2002, 35:228-35. 10.1086\/341022","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.05.00096704","article-title":"Significance of positive Stenotrophomonas maltophilia culture in acute respiratory tract infection","volume":"25","author":"Pathmanathan A","year":"2005","unstructured":"Pathmanathan A, Waterer GW. Significance of positive Stenotrophomonas maltophilia culture in acute respiratory tract infection. Eur Respir J. 2005, 25:911-4. 10.1183\/09031936.05.00096704","journal-title":"Eur Respir J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-003-3113-6","article-title":"Stenotrophomonas (Xanthomonas) maltophilia as an emerging opportunistic pathogen in association with HIV infection: a 10-year surveillance study","volume":"31","author":"Calza L","year":"2003","unstructured":"Calza L, Manfredi R, Chiodo F. Stenotrophomonas (Xanthomonas) maltophilia as an emerging opportunistic pathogen in association with HIV infection: a 10-year surveillance study. Infection. 2003, 31:155-61. 10.1007\/s15010-003-3113-6","journal-title":"Infection"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1086\/502197","article-title":"Risk factors for Stenotrophomonas maltophilia bacteremia in oncology patients: a case-control study","volume":"24","author":"Apisarnthanarak A","year":"2003","unstructured":"Apisarnthanarak A, Mayfield JL, Garison T, McLendon PM, DiPersio JF, Fraser VJ, Polish LB. Risk factors for Stenotrophomonas maltophilia bacteremia in oncology patients: a case-control study. Infect Control Hosp Epidemiol. 2003, 24:269-74. 10.1086\/502197","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref11","article-title":"Stenotrophomonas maltophilia bacteremia in adults: four years' experience in a medical center in northern Taiwan","volume":"37","author":"Wang WS","year":"2004","unstructured":"Wang WS, Liu CP, Lee CM, Huang FY. Stenotrophomonas maltophilia bacteremia in adults: four years' experience in a medical center in northern Taiwan. J Microbiol Immunol Infect. 2004, 37:359-65.","journal-title":"J Microbiol Immunol Infect"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5812\/jjm.23569","article-title":"Stenotrophomonas maltophilia infections in adults: primary bacteremia and pneumonia","volume":"8","author":"Gokhan Gozel M","year":"2015","unstructured":"Gokhan Gozel M, Celik C, Elaldi N. Stenotrophomonas maltophilia infections in adults: primary bacteremia and pneumonia. Jundishapur J Microbiol. 2015, 8:e23569. 10.5812\/jjm.23569","journal-title":"Jundishapur J Microbiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4103\/0974-2727.199639","article-title":"Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia infections","volume":"9","author":"Batra P","year":"2017","unstructured":"Batra P, Mathur P, Misra MC. Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia infections. J Lab Physicians. 2017, 9:132-5. 10.4103\/0974-2727.199639","journal-title":"J Lab Physicians"},{"key":"ref14","article-title":"Attention! There is a significant increase in Ttimetoprim sulfomethoxazole and levofloxacin resistance in Stenotrophomonas maltophilia strains isolated from clinical samples (2008-2016)","volume":"48","author":"Haz\u0131rolan G","year":"2018","unstructured":"Haz\u0131rolan G, Araz H, Celikbas AK, et al.. Attention! There is a significant increase in Ttimetoprim sulfomethoxazole and levofloxacin resistance in Stenotrophomonas maltophilia strains isolated from clinical samples (2008-2016). T\u00fcrk Mikrobiyoloji Cemiyeti Dergisi. 2018, 48:134-40.","journal-title":"T\u00fcrk Mikrobiyoloji Cemiyeti Dergisi"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/198740-clinical-characteristics-and-prognostic-factors-of-patients-with-stenotrophomonas-maltophilia-pneumonia-10-year-experience-from-a-single-center","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:54:09Z","timestamp":1707508449000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/198740-clinical-characteristics-and-prognostic-factors-of-patients-with-stenotrophomonas-maltophilia-pneumonia-10-year-experience-from-a-single-center"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,17]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.47187","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,17]]}}}